CONFIDENTIALITY AGREEMENT AMENDMENT NO. 1Confidentiality Agreement • March 18th, 2009 • Cv Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 18th, 2009 Company IndustryTHIS AMENDMENT (the “Amendment No. 1”) to the Confidentiality Agreement is entered into as of February 28, 2009, by and between CV Therapeutics, Inc., with principal place of business at 3172 Porter Drive, Palo Alto, CA 94304 (“CVT”), and Gilead Sciences, Inc., with principal place of business at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”).
CONFIDENTIALITY AGREEMENT AMENDMENT NO. 1Confidentiality Agreement • March 18th, 2009 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 18th, 2009 Company IndustryTHIS AMENDMENT (the “Amendment No. 1”) to the Confidentiality Agreement is entered into as of February 28, 2009, by and between CV Therapeutics, Inc., with principal place of business at 3172 Porter Drive, Palo Alto, CA 94304 (“CVT”), and Gilead Sciences, Inc., with principal place of business at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”).